Clinical trial
Analysis of Data Collected in the European Group for Blood and Marrow Transplantation (EBMT) Registry on a Cohort of Patients Receiving Plerixafor
NCT01362972 is registered in ClinicalTrials.gov with Genzyme, a Sanofi Company as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Analysis of Data Collected in the European Group for Blood and Marrow Transplantation (EBMT) Registry on a Cohort of Patients Receiving Plerixafor
- Lead sponsor
- Genzyme, a Sanofi Company
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 31, 2011
- Completion date
- June 30, 2016
- Enrollment
- 7,801 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.